Glaxosmithkline Share Price | |
---|---|
Price | 1,733.50 |
Bid | 1,732.50 |
Ask | 1,733.00 |
Change | 5.00 (0.29%) |
Volume | 4,237,108 |
Open | 1,733.00 |
High | 1,739.50 |
Low | 1,724.50 |
Prev. Close | 1,728.50 |
Currency | GBX |
---|---|
Issue Country | GB |
Shares in Issue | 4.08b |
Market Capitalisation | £70.69b |
Market Size | 1,500 |
52 Week High | 1,739.50 |
52 Week High Date | 03-May-2024 |
52 Week Low | 1,302.60 |
52 Week Low Date | 11-Jul-2023 |
# Trades | 8,855 |
---|---|
Vol. Sold | 1,443,878 |
Sold Value | £23.40m |
Vol. Bought | 2,667,934 |
Bought Value | £45.27m |
PE Ratio | 14.25576 |
Earnings | 121.60 |
Dividend | 55.50 |
Yield | 3.202% |
Date | Time | Trade Prc | Volume | Buy/Sell | Bid | Ask | Value | |
---|---|---|---|---|---|---|---|---|
03-May-24 | 15:21:19 | 1,731.50 | 5 | Unknown* | 1,732.50 | 1,733.00 | 86.58 | O Ordinary Delayed publication Was reported as OTC |
03-May-24 | 15:01:01 | 1,733.50 | 0 | Unknown* | 1,732.50 | 1,733.00 | 0.00 | O Ordinary Delayed publication Was reported as OTC |
03-May-24 | 16:49:22 | 1,733.50 | 185 | Buy* | 1,732.50 | 1,733.00 | 3,207 | O Ordinary |
03-May-24 | 16:35:18 | 1,733.50 | 1,624,313 | Buy* | 1,732.50 | 1,733.00 | 28m | UT Uncrossing Trade |
03-May-24 | 16:29:52 | 1,732.50 | 103 | Buy* | 1,799.00 | 1,655.50 | 1,784 | O Ordinary Trade was executed as an SI |
03-May-24 | 16:29:59 | 1,733.00 | 227 | Buy* | 1,732.50 | 1,733.00 | 3,934 | A Automatic Execution |
03-May-24 | 16:29:56 | 1,733.00 | 193 | Buy* | 1,732.50 | 1,733.00 | 3,345 | A Automatic Execution |
03-May-24 | 16:29:54 | 1,732.998 | 6 | Buy* | 1,732.50 | 1,733.00 | 103.98 | O Ordinary |
03-May-24 | 16:29:55 | 1,733.00 | 72 | Buy* | 1,732.50 | 1,733.00 | 1,248 | O Ordinary Trade was executed as an SI |
03-May-24 | 16:29:50 | 1,733.00 | 111 | Buy* | 1,732.50 | 1,733.00 | 1,924 | O Ordinary Trade was executed as an SI |
Announced | Traded | Action | Notifier | Price | Currency | Amount | Holding |
---|---|---|---|---|---|---|---|
19-Apr-24 | 16-Apr-24 | Buy Dividends | Hal Barron held the position of Non-Executive Director at the time of this trade.Hal Barron | 39.79 | USD | 2,906,213 | 3,370,704 |
19-Apr-24 | 16-Apr-24 | Buy Dividends | Emma Walmsley held the position of CEO at the time of this trade.Emma Walmsley | 1,611.28 | GBX | 1,840,922 | 2,190,842 |
15-Apr-24 | 12-Apr-24 | Buy Dividends | Anne Beal held the position of Independent Non-Executive Director at the time of this trade.Anne Beal | 40.96 | USD | 9 | 3,375 |
15-Apr-24 | 12-Apr-24 | Buy Dividends | Harry (Hal) C. Dietz held the position of Independent Non-Executive Director at the time of this trade.Harry (Hal) C. Dietz | 40.96 | USD | 9 | 3,118 |
15-Apr-24 | 12-Apr-24 | Buy Dividends | Hal Barron held the position of Non-Executive Director at the time of this trade.Hal Barron | 40.96 | USD | 13 | 464,491 |
At GSK, we unite science, technology and talent to get ahead of disease together